Loading Events

NHMRC Leadership Fellow & Head Cancer Immunotherapy Laboratory, Monash Biomedicine Discovery Institute

“Targeting Natural Killer cells in cancer immunotherapy”

Prof Huntington will present recent clinical evidence that natural killer (NK) cells are a key in the protective anti-tumour immune response and discuss new opportunities to target NK cell function to enhance cancer immunotherapy response rates across a more diverse range of cancers.

This event will be held online via Zoom. Registrations essential.


Share This Story, Choose Your Platform!